Ignite Creation Date:
2024-05-06 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04708379
Status:
COMPLETED
Last Update Posted:
2022-05-17
First Post:
2021-01-03
Brief Title:
Lifestyle Interventions for Overweight Adults With Mental Illness
Sponsor:
Wuhan University
Organization:
Wuhan University
Study Overview
Official Title:
Lifestyle Interventions for Overweight Adults With Severe Mental Illness in Shenzhen China
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine the lifestyle intervention on life quality and mental health among overweight adults with severe mental illness in Shenzhen China A total of 210 overweight adults with severe mental illness will be randomly allocated to intervention group and control group Participants in the intervention groups will receive a 10-month lifestyle intervention while the control group will be waitlisted A group of investigators will measure the anthropocentric indicators blood pressure lifestyle life quality and mental health for all participants
Detailed Description:
Previous studies suggest that overweight is an important risk factor for life quality and mental health among patients with severe mental illness Findings on Chinese adults regarding this issue are limited Thus we aim to assess the lifestyle intervention on life quality and mental health among overweight adults with severe mental illness in Shenzhen China
A total of 210 overweight adults with severe mental illness will be randomly allocated to two groups Participants in the intervention groups will receive a 10-month lifestyle intervention while the control group will be waitlisted
In the intervention group participants will receive lifestyle education delivered by trained staffs from Wuhan university The main objective of the lifestyle education is to raise participants awareness regarding the health complications related to obesity and subsequently to promote weight loss through behavioural modifications Participants will be advised to reduce energy intake by having three main meals and avoiding snacks limiting intake of sugary food and beverages as well as fried and fatty foods increasing intake of fruits and vegetables etc They will be asked to increase physical activity aiming for a minimum 150 min of moderate-intensity exercise per week andor 10000 steps per day
Outcome measurement include height weight blood pressure dietary habits sleep physical activity life quality and mental health that will be measured by a group of trained investigator for all participants
A total of 210 overweight adults with severe mental illness will be randomly allocated to two groups Participants in the intervention groups will receive a 10-month lifestyle intervention while the control group will be waitlisted
In the intervention group participants will receive lifestyle education delivered by trained staffs from Wuhan university The main objective of the lifestyle education is to raise participants awareness regarding the health complications related to obesity and subsequently to promote weight loss through behavioural modifications Participants will be advised to reduce energy intake by having three main meals and avoiding snacks limiting intake of sugary food and beverages as well as fried and fatty foods increasing intake of fruits and vegetables etc They will be asked to increase physical activity aiming for a minimum 150 min of moderate-intensity exercise per week andor 10000 steps per day
Outcome measurement include height weight blood pressure dietary habits sleep physical activity life quality and mental health that will be measured by a group of trained investigator for all participants
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None